BEGIN:VCALENDAR VERSION:2.0 PRODID:-//International Psoriasis Council - ECPv6.18.3//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:International Psoriasis Council X-ORIGINAL-URL:https://psoriasiscouncil.org X-WR-CALDESC:Events for International Psoriasis Council REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20220313T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20221106T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20230312T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20231105T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Europe/Rome BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20220327T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20221030T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20230326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20231029T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20240331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20241027T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Europe/Paris BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20220327T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20221030T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20230326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20231029T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20240331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20241027T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Atlantic/Faroe BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:WEST DTSTART:20220327T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:WET DTSTART:20221030T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:WEST DTSTART:20230326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:WET DTSTART:20231029T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:WEST DTSTART:20240331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:WET DTSTART:20241027T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Asia/Singapore BEGIN:STANDARD TZOFFSETFROM:+0800 TZOFFSETTO:+0800 TZNAME:+08 DTSTART:20220101T000000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Asia/Tokyo BEGIN:STANDARD TZOFFSETFROM:+0900 TZOFFSETTO:+0900 TZNAME:JST DTSTART:20220101T000000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/Chicago BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20220313T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20221106T070000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20230312T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20231105T070000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20240310T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20241103T070000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20231213T063000 DTEND;TZID=America/New_York:20231213T073000 DTSTAMP:20231227T195717Z CREATED:20230809T193103Z LAST-MODIFIED:20231227T195717Z UID:10000163-1702449000-1702452600@psoriasiscouncil.org SUMMARY:Global Webinar 4: Psoriasis and the Gut DESCRIPTION:Agenda\nWelcome and Introduction\nAkimichi Morita\, MD\, PhD\, Japan \nGenetic Insights into IBD and Psoriasis: Shared Features and Unique Characteristics\nAlex Tsoi\, MS\, PhD\, United States \nImmunopathogenesis of IBD: Pathways and Therapeutic Challenges\nKiyoshi Takeda\, MD\, PhD\, Japan \nCase Study: The Complex Relationship between IBD and Psoriasis\nFrancis Lai\, MBBS\, FACD\, Australia \nPanel Discussion\nFaculty \nClosing Comments and Adjourn\nAkimichi Morita\, MD\, PhD\, Japan \n  \nProgram Chair\nAkimichi Morita\, MD\, PhDNagoya City University West Medical Center and Nagoya City University Graduate School of Medical SciencesNagoya\, JapanIPC Board Member\n Bio\n \nProgram Faculty\nFrancis Lai\, MBBS\, FACDSkin Health InstituteMelbourne\, AustraliaIPC Jr. Councilor\n Bio\n Kiyoshi Takeda\, MD\, PhDImmunology Frontier Research Center\, Osaka University \nOsaka\, Japan\n Bio\n Alex Tsoi\, MS\, PhDUniversity of MichiganAnn Arbor\, Michigan\, United StatesIPC Councilor\n Bio URL:https://psoriasiscouncil.org/event/global-webinar-4-psoriasis-and-the-gut/ CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Rome:20231110T091500 DTEND;TZID=Europe/Rome:20231110T120000 DTSTAMP:20240515T112557Z CREATED:20230919T191605Z LAST-MODIFIED:20240515T112557Z UID:10000169-1699607700-1699617600@psoriasiscouncil.org SUMMARY:IPC & ARDV Symposium: Psoriasis - A Complex Disease of All Ages DESCRIPTION:Agenda\nPART ONE \nThe Epidemiology of Psoriasis; Insights in Children and Older Adults \nLuigi Naldi\, MD\, Italy \nPsoriasis in Children: Diagnosis. Clinical Presentations\, Comorbidities. Available Treatments \nEmmanuel Mahé\, MD\, PhD\, France \nPatient Registry Data on the Treatment of Psoriasis in Children\nMarieke Seyger\, MD\, PhD\, Netherlands \nTreating Severe Psoriasis in Adult Patients with Severe Psoriasis Less Than 60 Years Old- A Personalized Approach\nMenno de Rie\, MD\, PhD\, Netherlands \nTreating Severe Psoriasis in Patients Over 60 Years Old – The Interplay Between Immunosenescence and Psoriasis\nLluis Puig\, MD\, PhD\, Spain \nDiscussion \nPART TWO \nPsoriasis – Interesting Cases Presented By Residents\n1. Clinical Case 1\n2. Clinical Case 2\n3. Clinical Case 3\n4. Clinical Case 4\n5. Clinical Case 5 \nCLOSING COMMENTS AND ADJOURN \nProgram Chair\nLluís Puig\, MD\, PhDHospital de la Santa Creu i Sant PauBarcelona\, SpainIPC Board Member\n Bio\n George-Sorin Tiplica\, MD\, PhDCarol Davila University of Medicine and PharmacyBucharest\, RomaniaIPC Councilor\n Bio\n \nProgram Faculty\nMenno de Rie\, MD\, PhDUniversity of AmsterdamAmsterdam\, NetherlandsIPC Councilor Emeritus\n Bio\n Luigi Naldi\, MDSan Raffaele HospitalMilan\, ItalyIPC Councilor\n Bio\n Emmanuel Mahé \, MD\, PhDHôspital Victor DupouyArgenteuil\, FranceIPC Councilor\n Bio\n Marieke Seyger\, MD\, PhDRadboud University Medical CentreNijmegen\, NetherlandsIPC Councilor\n Bio\n \n  \nSymposium jointly presented with: URL:https://psoriasiscouncil.org/event/symposium-ardv2023/ CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2023/09/ARDV-2023-Event-Logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Paris:20231011T083000 DTEND;TZID=Europe/Paris:20231011T114500 DTSTAMP:20231120T190851Z CREATED:20220828T011305Z LAST-MODIFIED:20231120T190851Z UID:10000154-1697013000-1697024700@psoriasiscouncil.org SUMMARY:Symposium: Innovations in the Pathogenesis and Treatment of Psoriasis DESCRIPTION:Agenda\nWELCOME AND INTRODUCTION\nLluís Puig\, MD\, PhD\, Spain \nSESSION ONE: UPDATES ON THE PATHOGENESIS OF PSORIASIS \nNew Insights in the Pathogenesis of Psoriasis\nJohann Gudjonsson\, MD\, PhD\, United States \nUpdates on the Pathogenesis and Treatment of Generalized Pustular Psoriasis\nHervé Bachelez\, MD\, PhD\, France \nPanel Discussion\nLluís Puig\, MD\, PhD\, Spain\, moderator \nSESSION TWO: DISEASE RELAPSE AND PROGRESSION \nNew Understandings of Disease Relapse and Progression\nIrène Gallais Sérézal\, MD\, PhD\, France \nThe Natural History of Psoriasis: Insights into Clinical and Genetic Markers\nAxel Svedbom\, MSc\, PhD\, Sweden \nPanel Discussion\nLluís Puig\, MD\, PhD\, Spain\, moderator \nBREAK \nSESSION THREE: TREATMENT INNOVATIONS \nNew Paradigms in Oral Treatments for Psoriasis\nRichard Warren\, BSc\, MBChB\, MRCP\, PhD\, United Kingdom \nTYK2 Inhibitors for the Treatment of Psoriasis\nRonald Vender\, MD\, FRCPC\, Canada \nPanel Discussion\nLluís Puig\, MD\, PhD\, Spain\, moderator\nRichard Warren\, BSc\, MBChB\, MRCP\, PhD\, United Kingdom\, moderator \nCLOSING COMMENTS AND ADJOURN\nLluís Puig\, MD\, PhD\, Spain \n  \nProgram Chair\nLluís Puig\, MD\, PhDHospital de la Santa Creu i Sant PauBarcelona\, SpainIPC Board Member\n Bio\n \n  \nProgram Co-Chairs\nJohann Gudjonsson\, MD\, PhDUniversity of Michigan\, Department of DermatologyAnn Arbor\, Michigan\, United StatesIPC Board Member\n Bio\n Irène Gallais Sérézal\, PhDBesancon University HospitalBesançon\, FranceIPC Councilor\n Bio\n Richard Warren\, BSc\, MBChB\, MRCP\, PhDUniversity of ManchesterSalford\, United KingdomIPC Councilor\n Bio\n \n  \nProgram Faculty\nAxel Svedbom\, MSc\, PhDKarolinska InstitutetStockholm\, Sweden\n Bio\n Hervé Bachelez\, MD\, PhDHôpital Saint-Louis\, Imagine Institute for Human Genetic Diseases\, Paris Cité UniversityParis\, FranceIPC Councilor\n Bio\n Ronald Vender\, MD\, FRCPCVenderm Consulting Inc.White Rock\, British Columbia\, CanadaIPC Councilor\n Bio URL:https://psoriasiscouncil.org/event/symposium-eadv2023/ LOCATION:Messe Berlin Congress Center | Room 5\, Level 1 CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/EADV-2023-Event-Logo.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230928T090000 DTEND;TZID=America/New_York:20230928T100000 DTSTAMP:20231120T191955Z CREATED:20230516T180852Z LAST-MODIFIED:20231120T191955Z UID:10000162-1695891600-1695895200@psoriasiscouncil.org SUMMARY:Global Webinar 3: Psoriasis and the Joints DESCRIPTION:Agenda\nWelcome and Introduction\nLone Skov\, MD\, PhD\, Denmark \nEarly Signs and Markers of Psoriatic Arthritis and Disease Progression\nBent Deleuran\, MD\, PhD\, Denmark \nWhat’s New in Treatments for Psoriatic Arthritis\nFrank Behrens\, MD\, Germany \nDoes Treatment of Psoriasis Prevent Development of Psoriatic Arthritis?\nAlexis Ogdie\, MD\, MSCE\, United States \nQ & A and Closing Comments \nLone Skov\, MD\, PhD\, Denmark \n  \nProgram Chair\nLone Skov\, MD\, PhDHerlev and Gentofte Hospital\, University of CopenhagenHellerup\, DenmarkIPC Board Member\n Bio\n \nProgram Faculty\nFrank Behrens\, MDFraunhofer Institute for Translational Medicine and PharmacologyFrankfurt am Main\, Germany\n Bio\n Bent Deleuran\, MD\, DMSCAarhus University HospitalAarhus\, Denmark\n Bio\n Alexis Ogdie\, MD\, MSCEUniversity of Pennsylvania\, Perelman School of MedicinePhiladelphia\, Pennsylvania\, United States\n Bio\n \n  \nThis symposium is supported in part by Eli Lilly and Company. URL:https://psoriasiscouncil.org/event/global-webinar-3-psoriasis-and-the-joints/ CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Atlantic/Faroe:20230908T090000 DTEND;TZID=Atlantic/Faroe:20230908T170000 DTSTAMP:20231120T191223Z CREATED:20230831T174423Z LAST-MODIFIED:20231120T191223Z UID:10000164-1694163600-1694192400@psoriasiscouncil.org SUMMARY:Virtual Gunnar Lomholt Symposium DESCRIPTION:Agenda\nWelcome and Program Overview\nLone Skov\, MD\, PhD\, Denmark \nGunnar Lomholt’s Story and Thesis \nClaus Zachariae\, MD\, DMSci\, Denmark \nBig Data and Implications to Psoriasis \nTamar Nijsten\, MD\, PhD\, Netherlands \nWhat Genetic Association Tells Us About Phenotype: HLA and Beyond\nMichael Simpson\, MSc\, PhD\, United Kingdom \nBREAK \nComorbidities and Their Causal Relationship\nAlex Tsoi\, MS\, PhD\, United States \nLinking Genetics with Biological Mechanisms\nJohann Gudjonsson\, MD\, PhD\, United States \nKEYNOTE: A Genetic Epidemiologic History of Psoriasis\nJames T. Elder\, MD\, PhD\, United States \nBREAK \nPART TWO \nInflammatory Memory in Psoriasis\nLiv Eidsmo\, MD\, PhD\, Denmark \nImmunogenetic Dissection of Pustular Forms of Psoriasis\nHervé Bachelez\, MD\, PhD\, France \nKEYNOTE: Where is Psoriatic Arthritis Heading?\nOliver Fitzgerald\, MBBCh\, BAO\, MRCPI\, MRCP\, FRCPI\, MD\, Ireland \nThe History of the Faroe Islands\nErland Viberg Joensen\, PhD\, Faroe Islands \nBREAK \nScience and Practice of Therapeutic Drug Monitoring\nCatherine Smith\, MD\, United Kingdom \nTreatment Strategies and Targets for Severe Psoriasis\nUlrich Mrowietz\, MD\, Germany \nThe Need for Real World Evidence\nLone Skov\, MD\, PhD\, Denmark \n60 Years of Psoriasis Therapy: How Things Have Changed\nMatthias Augustin\, MD\, Germany \nClosing Comments and Adjourn\nJonathan Barker\, MD\, FRCP\, United Kingdom \nScientific Committee\nJonathan Barker\, MDSt John's Institute of Dermatology\, King's College LondonLondon\, United KingdomIPC Councilor Emeritus\n Bio\n Johann Gudjonsson\, MD\, PhDUniversity of Michigan\, Department of DermatologyAnn Arbor\, Michigan\, United StatesIPC Board Member\n Bio\n Lone Skov\, MD\, PhDHerlev and Gentofte Hospital\, University of CopenhagenHellerup\, DenmarkIPC Board Member\n Bio\n Claus Zachariae\, MD\, DMSciCopenhagen University HospitalHellerup\, DenmarkIPC Councilor\n Bio\n \nFaculty\nMatthias Augustin\, MDUniversity Medical Center Hamburg-EppendorfHamburg\, GermanyIPC Councilor\n Bio\n Hervé Bachelez\, MD\, PhDHôpital Saint-Louis\, Imagine Institute for Human Genetic Diseases\, Paris Cité UniversityParis\, FranceIPC Councilor\n Bio\n Liv Eidsmo\, MD\, PhDLEO Foundation Skin Immunology Research CenterCopenhagen\, Denmark\n Bio\n James Elder\, MD\, PhDUniversity of MichiganAnn Arbor\, Michigan\, United StatesIPC Councilor\n Bio\n Oliver Fitzgerald\, MD University College Dublin (UCD)Dublin\, Ireland\n Bio\n Erland Viberg Joensen\, PhDThe University of the Faroe IslandsTórshavn\, Faroe Islands\n Bio\n Ulrich Mrowietz\, MDUniversity Medical Center Schleswig-HolsteinKiel\, GermanyIPC Councilor\n Bio\n Tamar Nijsten\, PhDErasmus MCRotterdam\, Netherlands\n Bio\n Michael Simpson\, PhDKing's College LondonLondon\, United Kingdom\n Bio\n Catherine Smith\, MDKings College London\, and Guys and St Thomas NHS Foundation TrustLondon\, United KingdomIPC Secretary\n Bio\n Alex Tsoi\, MS\, PhDUniversity of MichiganAnn Arbor\, Michigan\, United StatesIPC Councilor\n Bio URL:https://psoriasiscouncil.org/event/virtual-gunnar-lomholt-symposium/ CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Asia/Singapore:20230703T143000 DTEND;TZID=Asia/Singapore:20230703T173000 DTSTAMP:20230911T191129Z CREATED:20220828T010430Z LAST-MODIFIED:20230911T191129Z UID:10000153-1688394600-1688405400@psoriasiscouncil.org SUMMARY:Symposium: Psoriasis Management and Treatment – An International Perspective DESCRIPTION:Agenda\nWELCOME AND INTRODUCTION\nSiew Eng Choon\, MBBS\, FRCP\, Malaysia \nA Patient-Inclusive Approach in the Treatment of Psoriasis: A Principal Without Borders\nClaudia de la Cruz\, MD\, Chile \nAn International Perspective on Value-Based Healthcare\nJo Lambert\, MD\, PhD\, Belgium \nGenetic Differences Across the Globe\nJohann Gudjonsson\, MD\, PhD\, United States \nPitfalls in Diagnosis and Phenotypic Differences Related to Skin of Color\nMohammad Huq\, MBBS. DDSc\, MSc-Dermatology\, MPH\, Bangladesh \nBREAK \nTherapeutic Challenges Related to Skin of Color\nMahira El Sayed\, MSc\, MD\, Egypt \nComorbidities of Psoriasis Across the World\nKathleen Gallant\, MPA\, United States \nAvailability of Therapies Across the World: Data from the GPA\nChris Griffiths\, OBE\, MD\, FMedSci\, United Kingdom \nEvery Patient in the World has the Right to Optimal Treatment \nHoseah Waweru\, MD\, Kenya \nCLOSING COMMENTS AND ADJOURN\nClaudia de la Cruz\, MD\, Chile \n  \nProgram Chairs\nClaudia de la Cruz\, MDClinica DermacrossSantiago\, ChileIPC Vice President/President-Elect\n Bio\n Siew Eng Choon\, MBBS\, FRCPHospital Sultanah Aminah Johor Bahru\, Clinical School Johor Bahru\, Jeffrey Cheah School of Medicine and Health Services\, Monash University MalaysiaJohor\, MalaysiaIPC Board Member\n Bio\n \nProgram Faculty\nMahira El Sayed\, MSc\, MDAin Shams UniversityCairo\, EgyptIPC Board Member\n Bio\n Kathleen Gallant\, MPAInternational Federation of Psoriasis AssociationsPittsburgh\, Pennsylvania\, United States\n Bio\n Johann Gudjonsson\, MD\, PhDUniversity of Michigan\, Department of DermatologyAnn Arbor\, Michigan\, United StatesIPC Board Member\n Bio\n Christopher Griffiths\, OBE\, MD\, FMedSciUniversity of Manchester and King’s College LondonLondon\, United KingdomIPC Honorary Founder\n Bio\n Mohammad Huq\, MBBS. DDSc\, MSc-Dermatology\, MPHPsoriasis Awareness Club Bangladesh\, PresidentDhanmondi\, Dhaka\, BangladeshIPC Councilor\n Bio\n Jo Lambert\, MD\, PhDGhent University HospitalGhent\, BelgiumIPC Councilor\n Bio\n Hoseah Waweru\, MDIFPA International Federation of Psoriasis AssociationsNairobi County\, Kenya\n Bio\n \n  \nThis Symposium is supported in part by Bristol Myers Squibb and Eli Lilly and Company. URL:https://psoriasiscouncil.org/event/symposium-wcd2023/ LOCATION:Suntec Singapore Convention & Exhibition Centre | Room Nicoll 1\, Level 3 CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/WCD-Event-Logo.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230526T130000 DTEND;TZID=America/New_York:20230526T160000 DTSTAMP:20230911T190932Z CREATED:20221114T012258Z LAST-MODIFIED:20230911T190932Z UID:10000156-1685106000-1685116800@psoriasiscouncil.org SUMMARY:IPC & SOLAPSO Symposium: Advances in the Management of Psoriasis DESCRIPTION:Agenda\nPART ONE: MANAGEMENT OF HARD TO TREAT AREAS\nWelcome and Introduction to the IPC and SOLAPSO\nRicardo Romiti\, MD\, PhD\, Brazil & Fernando Valenzuela\, MD\, Chile \nAdvances in the Management of Scalp Psoriasis\nClaudia de la Cruz\, MD\, Chile \nHow I Treat the Scalp\nCésar Gonzalez\, MD\, Colombia \nAdvances in the Management of Nail Psoriasis\nEnrique Rivas\, MD\, Guatemala \nHow I Treat the Nails\nFernando Valenzuela\, MD\, Chile \nAdvances in the Management of Palmoplantar Psoriasis\nAnber Tanaka\, MD\, Brazil \nHow I Treat the Palms and Soles\nMarcelo Arnone\, MD\, Brazil \nPanel Discussion\nRicardo Romiti\, MD\, PhD\, Brazil – facilitator \nBREAK\nPART TWO: KEEP UP TO DATE: PSORIASIS IN 2023\nMethotrexate: What Have We Learned in 75 Years\nAngela Londoño\, MSc\, MD\, Colombia \nCLCI in Patients with Psoriasis\nRicardo Romiti\, MD\, PhD\, Brazil \nGPP: Still a Neglected Disease?\nJuan Raul Castro Ayarza\, MD\, Colombia \nWhat´s the Role of Small Molecules in the Treatment of Psoriasis?\nGabriel Magariños\, MD\, Argentina \nNew Biologics\nAndré Esteves de Carvalho\, MD\, PhD\, Brazil \nPanel Discussion\nEnrique Rivas\, MD\, Guatemala – facilitator \n\nAttendees must be registered for the RADLA meeting to attend. Register now!\nProgram Chairs\nEnrique Rivas\, MDDERMOS Research CenterGuatemala City\, GuatemalaIPC Councilor\n Bio\n Ricardo Romiti\, MD\, PhDUniversity of Sao Paulo BrazilSão Paulo\, BrazilIPC Councilor\n Bio\n Fernando Valenzuela\, MDUniversity of Chile\, University of the AndesSantiago\, ChileIPC Councilor\n Bio\n \nProgram Faculty\nMarcelo Arnone\, MDHospital das Clínicas of University of São Paulo Medical School\nSão Paulo\, Brazil\n Bio\n André Carvalho\, MD\, PhDHospital Moinhos de Vento\nPorto Alegre\, BrazilIPC Board Member\n Bio\n Juan Raul Castro Ayarza\, MD\, MSUniversidad Nacional de Colombia. Grupo colombiano de psoriasis COLPSORBogotá\, ColombiaIPC Councilor\n Bio\n Claudia de la Cruz\, MDClinica DermacrossSantiago\, ChileIPC Vice President/President-Elect\n Bio\n César Gonzalez\, MDClinica Universitaria ColombiaBogota\, ColombiaIPC Councilor\n Bio\n Angela Londoño\, MSc\, MDCES UniversityMedellin\, ColombiaIPC Councilor\n Bio\n Gabriel Magariños\, MDUniversity of SalvadorBuenos Aires\, Argentina\n Bio\n Anber Tanaka\, MDEvangélico Mackenzie University Hospital of ParanáParaná\, Brazil\n Bio\n \n  \nSymposium jointly presented with:\n \n  \nThis Symposium is supported in part by Bristol Myers Squibb. URL:https://psoriasiscouncil.org/event/radla-2023-agenda/ LOCATION:Viasoft (UP Expo) – Curitiba\, Room Number 09\, Located at ASA 3 CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/11/RADLA-2023-Event-Logo.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Asia/Tokyo:20230510T113000 DTEND;TZID=Asia/Tokyo:20230510T150000 DTSTAMP:20230911T191004Z CREATED:20220827T191253Z LAST-MODIFIED:20230911T191004Z UID:10000152-1683718200-1683730800@psoriasiscouncil.org SUMMARY:Symposium: Disease Memory and Disease Modification in Psoriasis DESCRIPTION:Agenda\nPART ONE: LECTURES \nWelcome and Introduction\nJohann Gudjonsson\, MD\, PhD\, United States \nTissue Resident Memory Cells\nRachael Clark\, MD\, PhD\, United States \nEpigenetic Inflammatory Memory\nLiv Eidsmo\, MD\, PhD\, Denmark \nDisease Modification\nCurdin Conrad\, MD\, Switzerland \nFuture Directions in Psoriasis Research\nNicole Ward\, PhD\, United States \nPanel Discussion\nJohann Gudjonsson\, MD\, PhD\, United States – facilitator \nBREAK \nPART TWO: POSTER PRESENTATIONS \nIntroduction to Poster Presentations\nCurdin Conrad\, MD\, Switzerland \nUncovering Antigen Triggers in Genetically Predisposed Psoriasis Patients\nAsolina Braun\, PhD – Monash University\, Melbourne\, Australia \nThe Clinical and Immunological Features of Immune Checkpoint Inhibitors-Related Psoriasis\nLai-Ying Lu\, MD – Department of Dermatology and Aesthetic Medicine Center\, Jen-Ai Hospital\, Taichung\, Taiwan & Chang Gung Memorial Hospital\, Linkou\, Taoyuan\, Taiwan \nDNA Methyltransferase DNMT1 Deficiency in Keratinocyte Ameliorates IMQ-Induced Psoriasis-Like Dermatitis\nChunyuan Guo – Shanghai Skin Disease Hospital\, Tongji University School of Medicine\, Shanghai\, China \nIxekizumab Reduces Key IL-17 And IL-23 Pathway Genes More Rapidly Than Guselkumab\nLam Tsoi\, PhD – University of Michigan\, Ann Arbor\, Michigan\, United States \nComparative Efficacy of Biologic and Oral Agents in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis\nWilson Liao\, MD – University of California San Francisco\, San Francisco\, California\, United States \nEpidermal Keratinocytes from Psoriatic Resolved Skin Keep Disease Residual Transcriptomic and Epigenomic Profiles\nAmeneh Ghaffarinia\, MD – University of Szeged\, Szeged\, Hungary \nEarly Intervention with Secukinumab May Affect the Establishment of Tissue Memory in Psoriasis\nJohann Gudjonsson\, MD\, PhD – University of Michigan\, Ann Arbor\, Michigan\, United States \nRNA-Seq Helps Elucidate the Mechanism Of NB-UVB Through Comparison of The Treated Edges and Centers of Psoriatic Plaques\nSuphagan Boonpethkaew\, MD – Thammasat University\, Bangkok\, Thailand \nClosing Comments and Adjourn\nCurdin Conrad\, MD\, Switzerland \n\nAttendees must be registered for the ISID meeting to attend. Register now!\n  \nProgram Chairs\nJohann Gudjonsson\, MD\, PhDUniversity of Michigan\, Department of DermatologyAnn Arbor\, Michigan\, United StatesIPC Board Member\n Bio\n Curdin Conrad\, MDUniversity Hospital of LausanneLausanne\, SwitzerlandIPC Board Member\n Bio\n \nProgram Faculty\nRachael Clark\, MD\, PhDHarvard Medical SchoolBoston\, Massachusetts\, United States\n Bio\n Liv Eidsmo\, MD\, PhDLEO Foundation Skin Immunology Research CenterCopenhagen\, Denmark\n Bio\n Nicole Ward\, PhDVanderbilt University Medical Center and Vanderbilt UniversityNashville\, Tennessee\, United StatesIPC Councilor\n Bio URL:https://psoriasiscouncil.org/event/symposium-isid2023/ LOCATION:Keio Plaza Hotel Tokyo\, Room C (Nishiki) – 4F (south tower) CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/ISID-Event-Logo.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Paris:20230418T153000 DTEND;TZID=Europe/Paris:20230418T163000 DTSTAMP:20230502T183440Z CREATED:20230221T015321Z LAST-MODIFIED:20230502T183440Z UID:10000160-1681831800-1681835400@psoriasiscouncil.org SUMMARY:Global Webinar 2: Psoriasis in Patients with Cancer or Chronic Infections DESCRIPTION:Agenda\nWelcome and Introduction\nLluís Puig\, MD\, PhD\, Spain \nPsoriasis and Cancer: Epidemiologic Association\nLone Skov\, MD\, PhD\, Denmark \nPsoriasis Treatment and Cancer: New Perspectives\nPaolo Gisondi\, MD\, Italy \nPsoriasis Treatment and Chronic Infections\nRicardo Romiti\, MD\, PhD\, Brazil \nQ & A and Closing Comments \nLluís Puig\, MD\, PhD\, Spain \n  \nProgram Chair\nLluís Puig\, MD\, PhDHospital de la Santa Creu i Sant PauBarcelona\, SpainIPC Board Member\n Bio\n \nProgram Faculty\nPaolo Gisondi\, MDUniversity of VeronaVerona\, ItalyIPC Councilor\n Bio\n Ricardo Romiti\, MD\, PhDUniversity of Sao Paulo BrazilSão Paulo\, BrazilIPC Councilor\n Bio\n Lone Skov\, MD\, PhDHerlev and Gentofte Hospital\, University of CopenhagenHellerup\, DenmarkIPC Board Member\n Bio URL:https://psoriasiscouncil.org/event/psoriasis-in-patients-cancer-chronic-infections/ CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Chicago:20230316T140000 DTEND;TZID=America/Chicago:20230316T170000 DTSTAMP:20230425T184240Z CREATED:20230214T200125Z LAST-MODIFIED:20230425T184240Z UID:10000151-1678975200-1678986000@psoriasiscouncil.org SUMMARY:Symposium: Psoriasis: Using the Right Treatment in the Right Patient at the Right Time DESCRIPTION:Agenda\nPART ONE: LECTURES \nWelcome and Introduction\nPeter van de Kerkhof \nPrecision Medicine\, Including Early Active Intervention \nChristopher Griffiths \nCutting Edge Topical Medications\nLinda Stein Gold \nCutting Edge Systemic Treatments: Oral and Biologic\nAlexander Egeberg \nConsidering Comorbidities in Treatment Planning \nAndrew Blauvelt \nPanel Discussion \nLinda Stein Gold\, facilitator \nBREAK \nPART TWO: CHALLENGING CASES \nChallenging Case 1: A Patient with GPP\nJaquelini Barboza da Silva \nChallenging Case 2: A Patient with Multiple Comorbidities\nÁlvaro González-Cantero \nChallenging Case 3: A Patient with Active Cancer\nMatt Vesely \nQ & A – Speaker Panel\nPeter van de Kerkhof\, facilitator \nCLOSING COMMENTS AND ADJOURN\nPeter van de Kerkhof \n  \nProgram Chairs\nLinda Stein Gold\, MDHenry Ford Health SystemWest Bloomfield\, Michigan\, United StatesIPC Councilor\n Bio\n Peter van de Kerkhof\, MD\, PhDInternational Psoriasis CouncilNijmegen\, NetherlandsIPC Chief Medical Officer\n Bio\n \nProgram Faculty\nAndrew Blauvelt\, MD\, MBAUniversity of Maryland School of MedicineBaltimore\, Maryland\, United StatesIPC Board Member\n Bio\n Alexander Egeberg\, MD\, PhD\, DMScUniversity of Copenhagen and Bispebjerg HospitalCopenhagen\, Denmark\n Bio\n Christopher Griffiths\, OBE\, MD\, FMedSciUniversity of Manchester and King’s College LondonLondon\, United KingdomIPC Honorary Founder\n Bio\n \nCase Presenters\nJaquelini Barboza da Silva\, MDSanta Cruz UniversitySanta Cruz do Sul\, BrazilIPC Councilor\n Bio\n Álvaro González-Cantero\, MD\, PhDHospital Ramón y Cajal University HospitalMadrid\, SpainIPC Councilor\n Bio\n Matthew Vesely\, MD\, PhDYale UniversityNew Haven\, Connecticut\, United StatesIPC Jr. Councilor\n Bio\n \n\nThis symposium is supported in part by \nLead Sponsors \n              \n Supporting Sponsor\n \n  \nThe content of this session and opinions expressed by presenters are those of the respective presenting society or presenters and do not represent an endorsement by\, nor imply that the session content has been evaluated or approved by the American Academy of Dermatology or corporate sponsors. URL:https://psoriasiscouncil.org/event/symposium-aad2023/ LOCATION:New Orleans Ernest N. Morial Convention Center | Room 275/276/277\, Floor 2 CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/06/AAD-Event.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Paris:20230119T153000 DTEND;TZID=Europe/Paris:20230119T163000 DTSTAMP:20230220T200514Z CREATED:20221116T014532Z LAST-MODIFIED:20230220T200514Z UID:10000157-1674142200-1674145800@psoriasiscouncil.org SUMMARY:Global Webinar 1: Current Knowledge and Future Directions: Psoriasis and Heart Disease DESCRIPTION:Agenda\nWelcome and Introduction \nAndy Blauvelt \nPathophysiologic Links Between Psoriasis and Heart Disease \nMichael Garshick \nExploring Whether Systemic Therapy for Psoriasis Improves Heart Disease in Clinical Trials \nJoel Gelfand \nInvestigating Real-World Databases to Determine Whether Systemic Therapy for Psoriasis Improves Heart Disease \nMona Ståhle \nQ & A and Closing Comments \nAndy Blauvelt \n  \nProgram Chair\nAndrew Blauvelt\, MD\, MBAUniversity of Maryland School of MedicineBaltimore\, Maryland\, United StatesIPC Board Member\n Bio\n \nProgram Faculty\nJoel Gelfand\, MD\, MSCEUniversity of PennsylvaniaPhiladelphia\, Pennsylvania\, United StatesIPC Treasurer\n Bio\n Michael Garshick\, MDNYU Langone HealthNew York\, New York\, United States\n Bio\n Mona Ståhle\, MD\, PhDDepartment of Medicine\, Karolinska InstitutetStockholm\, Sweden\n Bio URL:https://psoriasiscouncil.org/event/gw1-psoriasis-heart-disease/ CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif END:VEVENT END:VCALENDAR